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Breast cancer patients of lower socioeconomic status tend to have poorer survival. Among 10865 cases of breast cancer from the
East Anglian Cancer Registry diagnosed between 1982 and 1993, we estimated the extent to which the differences in survival by
socioeconomic status, measured by both occupational and area-based methods, can be explained by differences between
socioeconomic groups in stage and morphological type of tumour. In univariate survival analyses, lower social class (manual
occupation) was associated with a relative hazard of 1.32 (95% CI 1.12–1.55) for death from breast cancer as underlying cause.
Women resident in the most deprived area had a relative hazard of 1.21 (0.95–1.54) for death from breast cancer as underlying
cause. Stage of disease accounted for 28% of the effect of social class on survival but for none of the effect of deprivation category.
Morphological type accounted for 3% of the effect of social class and none of the effect of deprivation category. Thus, stage at
presentation explains some but not all of the socioeconomic differences in breast cancer survival. Future research on histological
grade and socioeconomic status is indicated.
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Ethnic and socioeconomic effects on breast cancer survival are a
continuing issue in breast cancer research (Meng et al, 1997;
Pollock and Vickers, 1997; Thomson et al, 2001; English et al, 2002;
Newman et al, 2002). Although affluent women have a higher
incidence of breast cancer than socially deprived, several studies
using individual and area-based measures have shown that
deprived women with breast cancer from low socioeconomic
groups have poorer survival from disease (Carnon et al, 1994;
Kogevinas and Porta, 1997; Meng et al, 1997; Pollock and Vickers,
1997; Thomson et al, 2001). Possible explanations of the finding
include later diagnosis, and consequently a more advanced stage of
tumour in poorer women, and differences in care and treatment of
the cancer among women from deprived and affluent areas
(Twelves et al, 1998). Previous studies suggest that neither
explanation fully accounts for the phenomenon (Carnon et al,
1994; Macleod et al, 2000b; Thomson et al, 2001).
If the poorer prognosis of low-status women is mainly explicable
by a higher stage of tumour at presentation, then we should
intervene in the area of early detection. If a substantial and
significant association between poorer prognosis and low socio-
economic status persists after adjusting for stage of tumour, then
this would suggest that we should intervene in the area of
treatment. If tumours in women with low socioeconomic status
appear to be different ab initio in terms of aggressive potential, as
measured by morphological/histological type, then this would
point to more effective targeting of therapy to the tumour, and also
suggests that such women may be suitable candidates for
chemoprevention studies. In this study, we investigate the
consequences of adjustment for stage and morphology in survival
in 10865 breast cancer cases in East Anglia.
MATERIALS AND METHODS
In total, 10865 breast cancer cases were included in our study
drawn from the Eastern Anglian Cancer Registry, and diagnosed
between 1982 and 1993 in four hospitals of the East Anglia region:
Addenbrooke’s Hospital, Cambridge; the Norfolk and Norwich
Hospital, Norwich; the Ipswich Hospital, Ipswich and the West
Suffolk Hospital, Bury St Edmunds.
The following variables, obtained from the East Anglia Cancer
Registry data base, were treated as explanatory and/or confound-
ing in our analysis: histological stage of tumour, grade of tumour,
morphology of tumour, social class as determined by patient
occupation and deprivation category as determined by postcode of
residential area at the time of diagnosis. Stage was as defined in the
TNM system. Where available, the grade of the tumour was coded
as grade 1 (well differentiated), grade 2 (moderately differentiated)
and grade 3 (poorly differentiated). Tumour morphology was
coded in terms of the following six categories: ductal, medullary,
lobular, mucinous/tubular, adenocarcinoma not otherwise speci-
fied and others.
Socioeconomic status was represented in terms of census area of
residence and occupation. Social class was initially represented in
terms of five categories, I, II, IIIN, IIIM, IV and V. Owing to the
relatively large numbers of missing data on occupation, we had a
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collapsed the five categories into two, with the first level
representing categories I, II and IIIN, and the second level
representing the categories IIIM, IV and V. This essentially splits
the occupations into manual and nonmanual. We used as a second
measure of socioeconomic status the Carstairs index based on
indices of affluence/poverty in the area of residence (Morris and
Carstairs, 1991). This was ascertained from the patient’s postcode.
We also adjusted for age at diagnosis.
Survival rates were estimated using the Kaplan–Meier product
limit method. Cox’s (1972) regression model for censored survival
data was applied to our data to study the dependence of hazard of
death on the explanatory variables, taking account of potential
confounders. We had data on 6289 deaths out of a total of 10865
breast cancer cases; of these, 1383 died from breast cancer as the
underlying cause, this being our end point. We also performed a
secondary survival analysis for death from any cause in breast
cancer cases. Numbers available for different analyses vary due to
different numbers with missing data on the explanatory variables,
since for each analysis, we wished to use as much information as
was available.
Our analysis consisted of two main phases. In the first phase, we
performed a collection of analyses adjusted for age alone to
estimate the hazard ratios (HR) associated with the explanatory
variables of interest, without any adjustment for the effect of the
remaining variables. In the second phase of the analysis, we used
Cox’s model to perform a multivariate regression analysis in which
the joint impact of more than one explanatory variable on hazard
of death is simultaneously modelled. This analysis led to
estimation of an adjusted RR for each explanatory variable of
interest. This was used to ascertain whether adjustment for stage
or morphology accounted for more of the observed effect of
socioeconomic status. We used the attributable proportion
(Freedman et al, 1992) to estimate the extent to which adjustment
for the tumour attributes accounted for differences in survival by
socioeconomic group.
RESULTS
Table 1 shows numbers of cases and deaths from breast cancer as
underlying cause, age-adjusted hazard ratio estimates and simple
5-year survival rates for the main explanatory variables. Increases
in risk of death were noted for advanced stage, poor histological
grade, the ductal, lobular and ‘others’ morphology categories and
low socioeconomic status by either social class (occupational
measure) or deprivation category (area of residence measure).
Adjustment for histological grade has not been presented since, for
many of the early cancer notifications, grade was not available. The
unadjusted effect of social class on risk of death from breast cancer
is clearly significant (Po0.001), whereas that of deprivation
category is only suggestive (P¼0.1). The difference between the
highest and the lowest deprivation groups approaches significance
(P¼0.1).
Table 2 shows estimated hazard ratios and corresponding 95%
confidence intervals (CIs) by deprivation category, adjusting for
stage and age for breast cancer deaths only. The results show that
adjusting for stage did not substantially change the estimated
hazard ratio or the CI. Freedman’s estimate of the percentage of
the effect of the most deprived category attributable to stage is 0%.
This suggests that the survival disadvantage of women in the ‘most
deprived’ category cannot be explained in terms of a more
advanced stage at diagnosis.
Table 1 Basic data and age-adjusted estimates of survival effects by univariate analysis
Factors Category No. of cases No. of deaths
a 5-year survival probability (95% CI ) HR (95% CI)
Stage 1 3469 260 0.96 0.95–0.97 1.00 —
2 4230 651 0.91 0.89–0.92 2.40 2.07–2.78
3 1504 237 0.89 0.81–0.87 3.56 2.97–4.26
4 698 142 0.62 0.55–0.69 11.31 9.17–13.93
Grade 1 293 12 0.98 0.94–0.99 1.00 —
2 665 103 0.89 0.85–0.91 4.08 2.24–7.42
3 615 169 0.79 0.75–0.83 7.27 4.04–13.08
Morphology Ductal 4454 605 0.90 0.89–0.92 1.00 —
Medullary 154 15 0.93 0.86–0.97 0.63 0.37–1.05
Lobular 1314 205 0.91 0.89–0.93 1.12 0.95–1.31
Mucinous/tubular 298 15 0.99 0.96–1.00 0.30 0.18–0.52
Adenocarcinoma 1716 186 0.95 0.93–0.97 0.67 0.56–0.79
Others 2929 357 0.88 0.86–0.90 1.08 0.94–1.25
Social class High 2988 448 0.90 0.88–0.91 1.00 —
Low 1156 240 0.86 0.83–0.88 1.32 1.12–1.55
Deprivation Most affluent 2529 320 0.91 0.89–0.92 1.00 —
2 2983 376 0.91 0.90–0.93 1.01 0.87–1.18
3 2788 357 0.91 0.89–0.93 1.02 0.87–1.19
4 1904 240 0.91 0.89–0.93 1.00 0.84–1.18
Most deprived 661 90 0.91 0.88–0.94 1.21 0.95–1.54
aUnderlying cause.
Table 2 Survival by deprivation category adjusted for age and stage
(N¼9891)
Deprivation HR (95% CI)
1 (most affluent) 1.00 —
2 1.04 0.89–1.22
3 1.01 0.86–1.19
4 0.98 0.82–1.17
5 (most deprived) 1.23 0.96–1.56
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stage, for breast cancer deaths. The hazard ratio is substantially
attenuated by adjustment for age and stage. The Freedman
estimate of the proportion of the social class effect attributable
to age and stage was 28%. Thus, a proportion of the poorer
survival in lower social class women can be explained by their
more advanced stage at presentation. There still remains a
significant effect of social class, however, after adjustment.
Table 4 gives hazard ratio estimates by deprivation categories,
adjusting for age and morphology, for all deaths and for breast
cancer deaths only (underlying cause). Adjusting for ‘morphology’
did not substantially change the hazard ratio point and interval
estimates, in particular for the most deprived category. This
suggests that the apparent hazard disadvantage of women in the
‘most deprived’ category cannot be explained in terms of a more
unfavourable morphology of the tumour at diagnosis. The
Freedman measure of attributable proportion of the effect was
none at all.
Table 5 shows the hazard ratio estimates for the social class
categories adjusted for age and morphology; the adjustment for
morphology made little difference. The Freedman attributable
proportion was 3%.
It should be noted that for both social class and deprivation
category, simultaneous adjustment for stage and morphology did
not yield effects materially different from those observed after
adjusting for stage alone. Adjusted for both, the hazard ratio for
lower social class was 1.22 (95% CI 1.04–1.43), and for the most
deprived category the hazard ratio was 1.23 (95% CI 0.97–1.57).
In the secondary analysis using deaths from all causes, the
results were different. The age-adjusted hazard ratio for low social
class was 1.20 (95% CI 1.09–1.32), and for the highest deprivation
category it was 1.24 (95% CI 1.11–1.39). Stage accounted for 63%
of the social class effect on all-cause deaths (HR¼1.07, 95% CI
0.97–1.18) and for 31% of the deprivation category effect
(HR¼1.16, 95% CI 1.03–1.31). Adjustment for morphology
produced only minor changes to the age-adjusted hazard ratios
and did not attenuate at all those already adjusted for stage.
Table 6 shows stage and morphological type cross-tabulated with
socioeconomic status as measured by both social class and area-
based deprivation category. Stage was significantly associated with
social class (Po0.001) and deprivation category (P¼0.03), with
lower socioeconomic status being associated with more advanced
stage. Morphology was significantly related to social class
(Po0.001). This was partly due to fewer ductal carcinoma cases
in lower social classes, but in the main due to a larger number of
‘other’ category cases in the lower social classes. There was no
significant association between morphology and deprivation
category (P¼0.2), although again there were fewer ductal
carcinoma cases in the lowest category.
DISCUSSION
Our results add further to the evidence of an increased risk of
death in breast cancer patients of low socioeconomic status,
whether measured occupationally as social class or by an area-
based method. They also suggest that this increased risk is not
entirely attributable to morphological type or stage of disease.
Although stage tends to account for more of the effect, particularly
of the social class measure, there is still a substantial proportion of
the effect unaccounted for by stage (or by stage and morphology
together). This is consistent with the findings of Thomson et al
(2001), who observed that oestrogen receptor status and treatment
factors accounted for only 20% of the difference in survival
between patients of high and low socioeconomic status (as
measured by area of residence). Similarly, Newman et al (2002)
found that the survival differences by ethnic group in the US could
not be accounted for by stage of disease.
Nevertheless, we did find significantly poorer stage at presenta-
tion in patients of lower socioeconomic status, and this accounted
for some of the differences in survival. This is in disagreement with
the findings of Carnon et al (1994), who reported no significant
differences between socioeconomic groups with respect to tumour
size or node status. Our results are, however, partly consistent with
those of Macleod et al (2000a) who reported a higher rate of
clinically determined locally advanced disease in patients resident
in deprived areas. Brewster et al (2001) reported no significant
differences in stage among socioeconomic groups, but a reanalysis
of their tabular data on tumour size in breast cancer patients
shows a significant trend of increasing size with deprivation
(w¼5.17, 1 degree of freedom, P¼0.02). Thus, there is some
support for our association of stage and socioeconomic status in
the literature.
In our study, the distribution of morphological type was
associated with socioeconomic status, but it is difficult to interpret
this since 40% of the cases were classified simply as adenocarci-
noma or ‘other’. An association of morphological type with
socioeconomic status is not entirely unexpected, since Thomson
et al (2001) found a significant association between deprivation
category and oestrogen receptor status. More thorough morpho-
logical typing might account for more of the survival effect of
socioeconomic status. Also, in recent years, histological grade has
been registered in the majority of cases, so that when further
follow-up of recent cases becomes available, we will be able to
assess the extent to which histological grade may account for
socioeconomic differences in survival. Since it is known that some
risk factors, notably family history, vary in their effect on risk by
grade (Duffy et al, 1999) and it is likely that in some cases, grade
may actually deteriorate as the tumour grows (Tabar et al, 1996),
there is at least a possibility that grade is implicated in the
prognostic effect of socioeconomic status.
The association of survival with socioeconomic status (mea-
sured by either means) remained significant or close to significant
after adjustment for stage or morphological type or both. It is
notable that the adjustment accounted for a greater proportion of
Table 3 Survival by social class after adjusting for age and stage
(N¼3965)
Social class HR (95% CI)
High 1.00 —
Low 1.22 1.03–1.44
Table 4 Survival by deprivation category adjusted for age and
morphology (N¼10843)
Deprivation HR (95% CI)
1 (most affluent) — —
2 1.02 0.87–1.19
3 1.03 0.88–1.20
4 1.02 0.85–1.21
5 (most deprived) 1.23 0.96–1.55
Table 5 Survival by social class after adjusting for age and morphology
(N¼4141)
Social class HR (95% CI)
High 1.00 —
Low 1.31 1.12–1.54
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as the underlying cause of death. This may be due to
misclassification of cause of death, a direct effect of tumour
attributes on deaths from other causes or an increased risk of
death from other causes in association with more aggressive
treatment of more advanced tumours. Also, it is of interest that
whereas deprivation category was not significant as a predictor of
breast cancer death (although it was so for all-cause deaths), its
effect was more robust to adjustment. Stage accounted for at least
part of the effect of social class but for none of the effect of
deprivation category, suggesting that the nonoccupational aspects
of poverty captured by the deprivation score are associated with
survival independently of stage of disease. This may be related to
either host factors that affect survival generally or poorer access to
prompt and appropriate therapy.
The conclusions of the above are:
1. Survival rates in East Anglia confirm the poorer survival of
breast cancer patients of lower socioeconomic status.
2. This is only partly accounted for by differences in stage at
presentation and morphological type.
3. Assessment of the extent to which histological grade accounts
for the poorer survival of patients with lower socioeconomic
status is a target for future research.
4. Research is needed on access to and timing of appropriate
treatment in relation to socioeconomic status.
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